From disc replacement to Ozempic, Becker's reported on eight key spine and orthopedic studies since Oct. 28.
The Latest
Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw system in the U.S., according to a Nov. 22 news release.
Velys Spine, the robot from Johnson & Johnson's DePuy Synthes, is slated for a 2025 commercial release.
In the last seven days, Becker's reported on two health systems with big plans for orthopedic facilities.
A lawsuit brought by Geico alleging that an orthopedic surgeon and neurologist filed false claims against the insurance company was dismissed.
The impacts of GLP-1 weight loss drugs like Ozempic and Wegovy on arthroscopy patients are still being studied.
Four key elements have helped Justin Scheer, MD, of Los Angeles-based Cedars-Sinai, assess the value of new spine innovations in a growing landscape.
Tupelo, Miss.-based Specialty Orthopedic Group has announced a $30 million expansion project at its Oxford and Starkville, Miss., locations, with a commitment to adding 115 new jobs.
Prisma Health is expanding its orthopedic services in Laurens, S.C., establishing freestanding offices for its orthopedics practice and outpatient therapies through part of a $2 million expansion project, according to a Nov. 20 report from The Laurens County Advertiser.
Joint replacement and spine solutions manufacturer Medacta has added Anja Pomrehn as its group VP investor and financial media relations and environmental, social and governance investor.
